Argos Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Argos Therapeutics generated cash of -$35,424,886, which is more than the previous year. Cash used in financing activities reached the amount of -$2,684,153 last year. Net change in cash is therefore -$37,784,538.
Cash Flow
| 2014 | -45.24M | -7.79M | 56.96M |
|---|---|---|---|
| 2015 | -61.02M | 8.92M | 21.06M |
| 2016 | -40.67M | -14.32M | 101.81M |
| 2017 | -35.42M | 316.27K | -2.68M |
ARGS Cash Flow Statement (2014 – 2017)
| 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|
Cash at beginning of period | 52.97M | 6.16M | 37.22M | 33.29M |
Operating activities | ||||
Net income | -40.57M | -53.02M | -74.78M | -53.30M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 967.89K | 1.12M | 1.01M | 660.34K |
Stock-based compensation expense | 8.86M | 5.10M | 4.01M | 3.01M |
| Deferred income tax benefit | 8.86M | 5.10M | 4.01M | 3.01M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -385.23M | -262.25M | 153.44M | 86.99M |
Inventories | 362.56M | 260.41M | -207.53M | 0 |
Accounts payable | -2.22M | 1.19M | -136.98K | 543.41K |
Cash generated by operating activities | -35.42M | -40.67M | -61.02M | -45.24M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | -2.67B | -25.59B |
Investments In Property Plant And Equipment | -3.67M | -15.32M | -9.68M | -1.09M |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 316.27K | -14.32M | 8.92M | -7.79M |
Financing activities | ||||
Common Stock Issued | 15.5M | 5.5M | 8.57B | 49.82B |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | -15.18M | -52.97M | -6.16M | -37.22M |
Repayments of term debt | 0 | -100M | 0 | 0 |
Cash used in financing activities | -2.68M | 101.81M | 21.06M | 56.96M |
Net Change In Cash | -37.78M | 46.81M | -31.06M | 3.92M |
Cash at end of period | 15.18M | 52.97M | 6.16M | 37.22M |
| Data source | Data source | Data source | Data source |